Finanzwire Finanzwire
Basculer en Français
10797 Companies
233433 Keywords
162107 Articles
124605 Press releases
Headlines Articles Press releases Newron Pharmaceuticals S.p.A. Remove
  1. Home
  2. Companies
  3. Newron Pharmaceuticals S.p.A.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 03/17/2023 at 07:00, 3 years 4 months ago

    Newron to present at the 31st European Congress of Psychiatry  

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/14/2023 at 07:00, 3 years 4 months ago

    Newron announces 2022 financial results and provides outlook for 2023

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 02/16/2023 at 07:00, 3 years 5 months ago

    Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 01/03/2023 at 07:00, 3 years 7 months ago

    Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
Previous page
1 ... 7 8
Accesswire
  • Published on 08/04/2026 at 09:10, 1 hour 18 minutes ago

    HM Exploration Drills 18.45 Metres of 1.14% Cu, 2.42 % Zn, 16.74 g/t Ag and 0.32 g/t Au in Upper Lens; 5.42m of 1.99% Cu, 1.66% Zn, 15.39g/t Ag and 0.8g/t Au in Lower lens at Lewis Pilley's

  • Published on 08/04/2026 at 09:05, 1 hour 23 minutes ago

    BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline

  • Published on 08/03/2026 at 23:00, 11 hours 28 minutes ago

    Viemed Healthcare Announces Second Quarter 2026 Financial Results

  • Published on 08/01/2026 at 01:20, 3 days 9 hours ago

    Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage

  • Published on 08/01/2026 at 01:15, 3 days 9 hours ago

    Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination

View all ACCESSWIRE
EQS Group
  • Published on 08/04/2026 at 10:15, 13 minutes ago

    A Decade Beyond Boundaries: AKKO Celebrates 10th Anniversary with New European Products and IFA 2026 Showcase

  • Published on 08/04/2026 at 10:11, 16 minutes ago

    Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

  • Published on 08/04/2026 at 10:00, 28 minutes ago

    LR Health & Beauty SE publishes final 2025 annual report and continues to execute its strategic initiatives

  • Published on 08/04/2026 at 09:50, 38 minutes ago

    Strong Alliance, Smart Blueprint for New Power Systems | ZOE and Octopus Energy Sign Strategic Cooperation MOU to Co-Develop China's VPP and Smart Energy Landscape

  • Published on 08/04/2026 at 09:30, 58 minutes ago

    Original-Research: UmweltBank AG (von GBC AG): BUY

View all EQS
Les Echos
  • Published on 08/04/2026 at 08:15, 2 hours 13 minutes ago

    Covivio - Conditions of availability of the 2026 Half-year report

  • Published on 08/03/2026 at 18:45, 15 hours 43 minutes ago

    Covivio - Information on total number of voting rights and share capital

  • Published on 08/03/2026 at 18:00, 16 hours 28 minutes ago

    H1 2026 revenue

  • Published on 08/03/2026 at 17:45, 16 hours 43 minutes ago

    Monthly disclosure of the total number of shares and voting rights - July 2026

  • Published on 08/03/2026 at 17:45, 16 hours 43 minutes ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy